Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Markus Bieringer

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Haematologica|October 5, 2019
Clonal hematopoiesis in patients with anti-neutrophil cytoplasmic antibody-associated vasculitisChristopher Maximilian Arends, Marlene Weiss, Friederike Christen, et al.
Journal of Thrombosis and Haemostasis : JTH|January 9, 2022
Alternate-day dosing of caplacizumab for immune-mediated thrombotic thrombocytopenic purpuraLucas Kühne, Jessica Kaufeld, Linus A Völker, et al.
Journal of the American Society of Nephrology : JASN|January 17, 2024
Urinary CD4 + T Cells Predict Renal Relapse in ANCA-Associated VasculitisLuka Prskalo, Christopher M Skopnik, Nina Goerlich, et al.
Science Immunology|January 11, 2024
UNC93B1 variants underlie TLR7-dependent autoimmunityChristine Wolf, Ee Lyn Lim, Mohammad Mokhtari, et al.
Blood Advances|July 8, 2020
ADAMTS13 and VWF activities guide individualized caplacizumab treatment in patients with aTTPLinus A Völker, Jessica Kaufeld, Wolfgang Miesbach, et al.
Blood Advances|July 8, 2020
Real-world data confirm the effectiveness of caplacizumab in acquired thrombotic thrombocytopenic purpuraLinus A Völker, Jessica Kaufeld, Wolfgang Miesbach, et al.
Journal of Thrombosis and Haemostasis : JTH|January 25, 2023
Impact of first-line use of caplacizumab on treatment outcomes in immune thrombotic thrombocytopenic purpuraLinus A Völker, Jessica Kaufeld, Gesa Balduin, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Haematologica|October 5, 2019
Clonal hematopoiesis in patients with anti-neutrophil cytoplasmic antibody-associated vasculitisChristopher Maximilian Arends, Marlene Weiss, Friederike Christen, et al.
Journal of Thrombosis and Haemostasis : JTH|January 9, 2022
Alternate-day dosing of caplacizumab for immune-mediated thrombotic thrombocytopenic purpuraLucas Kühne, Jessica Kaufeld, Linus A Völker, et al.
Journal of the American Society of Nephrology : JASN|January 17, 2024
Urinary CD4 + T Cells Predict Renal Relapse in ANCA-Associated VasculitisLuka Prskalo, Christopher M Skopnik, Nina Goerlich, et al.
Science Immunology|January 11, 2024
UNC93B1 variants underlie TLR7-dependent autoimmunityChristine Wolf, Ee Lyn Lim, Mohammad Mokhtari, et al.
Blood Advances|July 8, 2020
ADAMTS13 and VWF activities guide individualized caplacizumab treatment in patients with aTTPLinus A Völker, Jessica Kaufeld, Wolfgang Miesbach, et al.
Blood Advances|July 8, 2020
Real-world data confirm the effectiveness of caplacizumab in acquired thrombotic thrombocytopenic purpuraLinus A Völker, Jessica Kaufeld, Wolfgang Miesbach, et al.
Journal of Thrombosis and Haemostasis : JTH|January 25, 2023
Impact of first-line use of caplacizumab on treatment outcomes in immune thrombotic thrombocytopenic purpuraLinus A Völker, Jessica Kaufeld, Gesa Balduin, et al.
Pageof 2